L-Carnitine L-Tartrate Ingredient
L-Carnitine L-Tartrate Powder Manufacturer & Supplier
L-Carnitine L-Tartrate powder is supplied for nutritional and sports-nutrition formulations requiring this specific carnitine form, with analytical specifications and product documentation available for ingredient qualification and commercial purchasing.
Product Information
L-Carnitine L-Tartrate Powder
Chemical and physical identifiers for specifying the correct L-Carnitine L-Tartrate raw material.
Malzeme Seçimi
L-Carnitine L-Tartrate for Formulation
L-Carnitine L-Tartrate combines L-Carnitine with L-tartaric acid in a defined salt form. Ingredient selection should therefore be based on the specific carnitine form required by the formulation.
Selecting the Correct L-Carnitine Form
L-Carnitine L-Tartrate should be specified by its complete ingredient name when sourcing material for a formulation. L-Carnitine base, L-Carnitine L-Tartrate and other carnitine forms have different composition profiles and should be evaluated against the formulation and purchasing specification separately.
Formülasyonla İlgili Hususlar
Review the ingredient form together with the intended dosage format, target L-Carnitine contribution and manufacturing process. For dry blends, capsules and tablets, physical properties such as particle size and density may also be relevant during formulation trials and scale-up.
Teknik Özellikler
L-Carnitine L-Tartrate Technical Specification
Analytical criteria covering identity, composition, physical characteristics, contaminants and microbiological quality.
| Test Item | Şartname | Result | Yöntem |
|---|---|---|---|
| Identity & Physical Characteristics | |||
| Tanımlama | Sample spectrum is consistent with the standard spectrum | Conform | IR |
| Görünüş | White crystals | Conform | Görsel |
| Çözünürlük | Clarification | Conform | Görsel |
| Spesifik Rotasyon | -9.5° to -11.0° | -10.46° | GB |
| pH | 3.0 to 4.5 | 3.74 | GB |
| Kurutma Kaybı | ≤0.5% | 0.07% | GB |
| Ateşleme Üzerinde Kalıntı | ≤0.5% | 0.08% | GB |
| Kompozisyon | |||
| L-Karnitin | 68.2 ± 1.0% | 67.93% | Titration |
| L-Tartrate | 31.8 ± 1.0% | 31.63% | Titration |
| Elemental & Contaminant Controls | |||
| Ağır Metaller | ≤10 ppm | <10 ppm | Ch.P |
| Kurşun | ≤3 ppm | <3 ppm | AAS |
| Arsenik | ≤1 ppm | <1 ppm | Ch.P |
| Cıva | ≤0.1 ppm | <0,1 ppm | AAS |
| Kadmiyum | ≤1 ppm | <1 ppm | AAS |
| Residue Methanol | ≤0.3% | <0.3% | Ch.P |
| Cyanide | Olumsuz | ND | Ch.P |
| Microbiological Controls | |||
| Total Plate Count | ≤1000 cfu/g | ND | Ch.P |
| Maya ve Küf | ≤100 cfu/g | ND | Ch.P |
| E. coli | Olumsuz | ND | Ch.P |
| Salmonella | Olumsuz | ND | Ch.P |
| Fiziksel Özellikler | |||
| Yığın Yoğunluğu | 0.4–0.8 g/ml | Conform | Physical |
| Tap Density | 0.5–0.9 g/ml | Conform | Physical |
| Mesh | Through 12 mesh | 100% passed | 12 mesh screen |
Uygulamalar
Applications for L-Carnitine L-Tartrate Powder
The ingredient can be evaluated across nutritional formats where L-Carnitine L-Tartrate is the specified carnitine form.
Sporcu Beslenmesi
Suitable for sports-nutrition concepts that specify L-Carnitine L-Tartrate as the carnitine source. Target active contribution should be calculated from the ingredient composition.
Kapsüller
For capsule development, evaluate the required ingredient loading together with capsule size, excipients and the physical behavior of the complete blend.
Tabletler
Tablet projects should consider ingredient loading, blend behavior and processing requirements during formulation trials before commercial scale-up.
Toz Karışımları
In dry formulations, evaluate distribution and handling with the actual carrier system and other ingredients used in the finished product.
Ingredient Qualification
Qualifying L-Carnitine L-Tartrate for Production
Ingredient approval should connect the required carnitine form with formulation performance, documentation and the commercial material intended for production.
Formulation Evaluation
Evaluate the material in the intended dosage form before commercial production, particularly where ingredient loading or powder behavior can affect processing.
Purchasing Qualification
Before moving from sample evaluation to a commercial order, align the approved material with the documentation and purchasing requirements used by your quality and procurement teams.
Ticari Tedarik
Bulk L-Carnitine L-Tartrate Supply
Packaging and documentation can be reviewed as part of commercial purchasing and supplier qualification.
Commercial Packaging
The documented commercial format is suitable for bulk ingredient purchasing. Confirm packaging requirements for the intended order and destination during quotation.
Product Documentation
Product documentation can be reviewed during ingredient qualification and before commercial purchasing to support internal quality and procurement procedures.
Commercial Inquiry
Request L-Carnitine L-Tartrate Pricing
Share your purchasing requirements so the product and commercial information can be matched to your formulation and supply needs.
Quantity & Destination
Provide your estimated purchasing quantity and destination country or region.
Finished-Product Format
Tell us whether the material is intended for capsules, tablets, powder blends or another nutritional format.
Purchasing Requirements
Include any internal qualification conditions or commercial requirements that should be considered with the quotation.
Sorgunuzu Gönderin
Share your company details and purchasing requirements.